<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001513'>Obesity</z:hpo>-associated type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is rapidly increasing throughout the world </plain></SENT>
<SENT sid="1" pm="."><plain>It is generally recognized that <z:chebi fb="15" ids="33243">natural products</z:chebi> with a long history of safety can modulate <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To investigate the development of <z:hpo ids='HP_0001513'>obesity</z:hpo> in response to a high fat diet (HFD) and to estimate the effect of L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> and an Egyptian Herbal mixture formulation (HMF) (consisting of T. chebula, Senae, rhubarb, black cumin, aniseed, fennel and licorice) on bodyweight, food intake, <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles, renal, hepatic, cardiac function markers, <z:chebi fb="23" ids="18059">lipid</z:chebi> Peroxidation, and the <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin levels in blood and liver tissue in rats </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: White male <z:mp ids='MP_0001189'>albino</z:mp> rats weighing 80-90 gm, 60 days old </plain></SENT>
<SENT sid="4" pm="."><plain>10 rats were fed a <z:mpath ids='MPATH_458'>normal</z:mpath> basal diet (Cr), 30 rats fed a high-fat diet (HFD) for 14 weeks during the entire study </plain></SENT>
<SENT sid="5" pm="."><plain>Rats of the HFD group were equally divided into 3 subgroups each one include 10 rats </plain></SENT>
<SENT sid="6" pm="."><plain>The first group received HFD with no supplement (HFD), the 2nd group HFD+L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> and the third group received HFD+HMF </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="16347,3424">Carnitine</z:chebi> and HMF were administered at 10th week (start time for treatments) for 4 weeks.Body weight, <z:chebi fb="23" ids="18059">lipid</z:chebi> profile &amp; renal function (<z:chebi fb="20" ids="16199">urea</z:chebi>, <z:chebi fb="3" ids="27226">uric acid</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi>) ALT &amp; AST activities, cardiac markers, (LDH, C.K-NAC and MB) the <z:mp ids='MP_0003674'>oxidative stress</z:mp> marker reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), and Malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) catalase activity, in addition to <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in serum &amp; tissues were analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Data showed that feeding HFD diet significantly increased final body weight, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (TG), total cholesterol, &amp; <z:chebi fb="15" ids="39026">LDL</z:chebi> concentration compared with controls, while significantly decreasing <z:chebi fb="17" ids="39025">HDL</z:chebi>; meanwhile treatment with L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi>, or HMF significantly normalized the <z:chebi fb="23" ids="18059">lipid</z:chebi> profile.Serum ALT, <z:chebi fb="20" ids="16199">urea</z:chebi>, <z:chebi fb="3" ids="27226">uric acid</z:chebi>, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, LDH, CK-NAC, CK-MB were significantly higher in the high fat group compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls; and administration of L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> or herbal extract significantly lessened the effect of the HFD </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, and high <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (IR) significantly increased in HFD in comparison with the control group </plain></SENT>
<SENT sid="10" pm="."><plain>The treatment with L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> or HMF improved the condition </plain></SENT>
<SENT sid="11" pm="."><plain>HFD elevated hepatic <z:chebi fb="14" ids="32506">MDA</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation associated with reduction in hepatic GSH and catalase activity; whereas administration of L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> or herbal extract significantly ameliorated these hepatic alterations </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: HFD induced <z:hpo ids='HP_0001513'>obesity</z:hpo> associated with a disturbed <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, defective <z:chebi fb="11" ids="22586">antioxidant</z:chebi> stability, and high values of IR parameters; this may have implications for the progress of <z:hpo ids='HP_0001513'>obesity</z:hpo> related problems </plain></SENT>
<SENT sid="13" pm="."><plain>Treatment with L-<z:chebi fb="1" ids="16347,3424">carnitine</z:chebi>, or HMF extract improved <z:hpo ids='HP_0001513'>obesity</z:hpo> and its associated metabolic problems in different degrees </plain></SENT>
<SENT sid="14" pm="."><plain>Also HMF has <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, hypolipidaemic insulin sensitizing effects </plain></SENT>
<SENT sid="15" pm="."><plain>Moreover HMF might be a safe combination on the organs whose functions were examined, as a way to surmount the <z:hpo ids='HP_0001513'>obesity</z:hpo> state; and it has a distinct anti-<z:hpo ids='HP_0001513'>obesity</z:hpo> effect </plain></SENT>
</text></document>